ImmunoGen Message Board - Msg: 27924149

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (5471)	2/2/2012 6:51:45 PM
From: rjk01	Read Replies (1) of 5665

from ohad hammer blog, the guy is on the money with almost every pick. He had imgn on his buy virtual portfolio few time but sold at the high a few months ago. Here are his thoughts on upcoming months I agree that teh 2nd part of this year and even more so next year could be transformational for IMGN. Positive p3 EMILIA data are already baked in but results from several programs are expected starting from late 2012. These include their IMGN901 p2 results, IMGN529 in NHL, Sanofi’s ADC for ovarian cancer and 2 Amgen programs. I am most excited about their folate receptor ADC but we’ll have data only in 2H13. Ohad

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next